“A few of our observations touched on the same areas as F.D.A.’s inspectional findings,” said Ray Godlewski, vice president for quality at Baxter’s medication delivery business. Mr. Godlewski refused to be more specific because, he said, of a confidentiality agreement with Scientific Protein.